StockTipsArenaBeta

BUY Indegene Limited — ICICI Securities

BUYIndegene Limited
Indegene share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)25 Sept 2026via Institutional / Brokerage Research

Entry₹608.95Inferred
Target₹750
Total upside +23.16%
Stop lossNot given
CMP₹666.21d ago
Active+9.40%+12.58%upside left 10 mo left
Follow ICICI Securities for new calls(62% target hit, 1145 closed calls)Get alertsWatch INDGN for new buy/sell callsGet alertsSee 4 other Long-term calls on INDGNSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:28 am IST
7 supporting10 neutral1 opposing
Supports the BUY call (7)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·2 Nov · 2w ago

Indegene reported strong Q2 FY27 performance with H1 USD revenue growth reaching a four-year high.

NSE · Press Release·29 Oct · 2w ago

(opens in new tab)

Indegene reported Q2 FY27 revenue of INR 11,223 million, up 39.5% YoY, with EBITDA of INR 1,873 million and PAT of INR 1,123 million, reflecting strong growth and stable margins.

BSE · Company Update·29 Oct · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·23 Sept · 2mo ago

Neutral / worth noting (10)

Indegene Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·29 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Indegene

All analyst calls on Indegene

More from ICICI Securities

Every call and its outcome